No Data
No Data
Why We're Not Concerned About Azenta, Inc.'s (NASDAQ:AZTA) Share Price
Azenta, Inc.'s (NASDAQ:AZTA) price-to-sales (or "P/S") ratio of 4.5x may not look like an appealing investment opportunity when you consider close to half the companies in the Life Sciences industry i
Teradir closed up 8.15%, Nvidia doubled and the ETF rose 7.17%, Nvidia rose 3.71%, and TSMC's ADR rose 4.33%, TSMC's ADR rose more than 2.7%, and Sijiaxun and Intel rose about 1.8%, and AMD and ST Semiconductor's ADR rose about 1.1%, Apple rose 0.5%, and
Teradir closed up 8.15%, Nvidia doubled and the ETF rose 7.17%, Nvidia rose 3.71%, and TSMC's ADR rose 4.33%, TSMC's ADR rose more than 2.7%, and Sijiaxun and Intel rose about 1.8%, and AMD and ST Semiconductor's ADR rose about 1.1%, Apple rose 0.5%, and Micron Technology closed down about 0.2%, and Azenta fell over 1.1%, and Knowles fell more than 1.5%, and Arm Holdings fell more than 1.9%, and Meta fell more than 10.5%.
Meta is currently down more than 13.1%, Nano-Micro Semiconductor, Arm Holdings, ASM International ADR, Intel, and Azenta are up at most 2.3% Seagate Technology, Micron Technology, Wolfspeed, TSMC ADR, Knowles, and Tower Semiconductors have dropped more th
Meta is currently down more than 13.1%, Nano-Micro Semiconductor, Arm Holdings, ASM International ADR, Intel, and Azenta are up at most 2.3% Seagate Technology, Micron Technology, Wolfspeed, TSMC ADR, Knowles, and Tower Semiconductors have dropped more than 1.8%. Applied materials, ultra-microcomputers, Asmack ADR, Nova, Qualcomm, AMD, Texas Instruments, etc. have fallen by as much as 0.8% Qorvo, Apple, Intel, and ST Semiconductor ADR, Cisco, and GF have risen by as much as 0.7%, and Nvidia rose 0.3% Nvidia doubles as long as ETF rises
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Needham: Maintaining the Azenta (AZTA.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $75.00 to $75.00.
Needham: Maintaining the Azenta (AZTA.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $75.00 to $75.00.
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
No Data